Curebase (Series B)
Funding Details
Awarder
Gaingels
Date Award
May 24, 2024
Vertical
Enterprise Software and Services
Valuation
$175,000,000
Company Info
Founders
Tom Lemberg
Market
Healthcare & Wellness
Coinvestors
Gilead Sciences,XFund,BOLD Capital Partners,GGV Capital,Industry Ventures
Company Description

Flexible, decentralized research solution. Curebase’s software technology and virtual staff enables participation and clinical data collection settings almost anywhere - from local clinics, to mobile care, telehealth, drive through sites, pharmacies and more. Curebase is a provider of decentralized clinical research software solutions and services to patients and medical providers.